Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
The FDA agreed to review Moderna’s experimental mRNA influenza vaccine after Moderna resubmitted its application with modifications.
The Chosun Ilbo on MSN
14.2M COVID-19 vaccines administered despite foreign substance reports
Foreign substances such as mold, hair, and silicon dioxide (silica) were found in COVID-19 vaccines, potentially introduced ...
The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...
Union Health Minister J P Nadda launched the indigenously manufactured tetanus and adult diphtheria vaccine in Kasauli. The ...
Union Health Minister JP Nadda on Saturday launched the indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine ...
In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.
Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.
InStyle on MSN
Meghan Markle and Prince Harry Plan Humanitarian Visit to Jordan Days After Ex-Prince Andrew's Arrest
They're continuing their work with the World Health Organization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results